1) Oral administration of thalidomide (1.5-3mg/kg), once a day 2) Oral administration of placebo (1.5-3mg/kg), once a day 1) Oral administration of thalidomide(1.5-3mg/kg), once a day 2) Oral administration of placebo (1.5- ...
Kawai Toshinao
Kawai Toshinao;Japan Agency for Medical Research and Development
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitis Double-blind placebo-controlled clinical trial of thalidomidefor chronic granulomatous disease-assoc ...
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitis - Clinical trial of thalidomide for CGD colitis Double-blind placebo-controlled clinical trial of thalidomidefor chronic granulomatous disease-assoc ...
Chronic granulomatous disease associated colitis
Oral administration of thalidomide (1.5-3mg/kg), once a day Oral administration of placebo (1.5-3mg/kg), once a day Oral administration of thalidomide(1.5-3mg/kg), once a day Oral administration of placebo (1.5-3mg/kg ...